Candel Therapeutics CADL
NASDAQ CADL
$10.64 -0.24 (-2.21%)
As of: Sep 30, 2026 · 1:08 PM EDT

Candel Therapeutics, Inc. (CADL) EBIT (2020 - 2026)

Updated

Candel Therapeutics' EBIT was -$26.75 million in Q2 2026, compared with -$11.18 million a year earlier.

Analysis

Candel Therapeutics, Inc. (CADL) EBIT (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Candel Therapeutics' EBIT was -$66.88 million through Jun 30, 2026; for FY2025, it was -$48.27 million.

  • In earlier years, EBIT was -$33.37 million in FY2024, -$38.39 million in FY2023, -$34.72 million in FY2022 and -$25.73 million in FY2021.
  • The Q2 2026 figure marks the lowest quarterly EBIT in data going back to Q2 2020.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -26.75 Mn
Dec 31, 2025 -15.75 Mn
Sep 30, 2025 -13.21 Mn
Jun 30, 2025 -11.18 Mn
Mar 31, 2025 -8.13 Mn
Dec 31, 2024 -8.14 Mn
Sep 30, 2024 -8.76 Mn
Jun 30, 2024 -8.57 Mn
Mar 31, 2024 -7.90 Mn
Dec 31, 2023 -10.32 Mn
Sep 30, 2023 -8.86 Mn
Jun 30, 2023 -9.58 Mn
Mar 31, 2023 -9.63 Mn
Dec 31, 2022 -8.10 Mn
Sep 30, 2022 -8.88 Mn
Jun 30, 2022 -8.75 Mn
Mar 31, 2022 -8.99 Mn
Dec 31, 2021 -7.74 Mn
Sep 30, 2021 -8.03 Mn
Jun 30, 2021 -5.30 Mn
API Access

Candel Therapeutics, Inc. EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=CADL&period=max&api_key=YOUR_API_KEY